Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This just might be who’s reverse merging into BRRN after all...
Good to see this finally receiving the attention it deserves after months of no volume and silence
This is the type of PR I like. Still 19 days until Q4 financials, plenty of time for another one.
???
Arguably because their financials don’t represent PPE financials yet, only from their infrastructure and UMCCO branches, neither of which are particularly strong companies right now. They should be able to acquire lower interest convertible notes if their Q4 financials are much better than the previous 700k revenue Q3.
Bold thing to say considering their PPE third-party negotiator branch didn’t become operational until Q4, and we haven’t seen their Q4 financials yet.
I’m assuming it’s because he’s naked shorting them.
You didn’t answer my post.
Hmm, if we check the note on Friday it pushes their total liabilities to an otherworldly amount of... 5 million. Coincidentally, they’ve also diluted 5 million since Harrington was added to their board. But oh no, they’re a diluting machine, and they have absolute piles of debt, far too many for them to ever surmount! Well, guess this means I have to sell all of my shares in exchange for a totally legit OTC stock that does not dilute, have any debt, or have a massive OS like maybe OZSC or any of the other 500 weed stocks that are pumped on any certain day
Man, the overreactions on this board kill me
One of my favorite quotes related to the stock market is by Warren Buffet, and it goes like this: “be fearful when others are greedy, and greedy when others are fearful.” Everybody is being too dramatic over them going down the past few months, even though the DD on them is the best you’ll find anywhere in the OTC world. Their next 10-Q comes out in February, and that’s when they will begin reporting the big numbers we’ve been waiting for. The only other OTC stock I can think of that has consistent acquisitions, potential, revenue, low OS and minimal dilution, and dedicated and established management is ALPP, and look what just happened to them. I expect to see all of you come February, at minimum.
Only one more day! Hopefully we get an 8-K to accompany the name change!
Merry Christmas y’all. The future is bright here :)
This is so much better than I expected. Don’t have to pay Tritanium employers or cost to run facilities, and still get masks for price of production. Billy never disappoints.
Presentation still hasn’t started...
60 mil in revenues in past 9 months and government contracts in the 100s of millions yet share price is 0.15 and market cap is 25 mil. Most underrated OTC stock right now, nobody can challenge them. Makes me wonder what it’ll take for them to become properly valued one day though.
Also EARS stock is rocketing today, so looks like FiveT is making quite the stack of money today. Good for them.
Is it just me, or is a 1:1000 RS a bit too much.
As someone that has been holding this stock quietly and patiently since August, I can assure you there are plenty of people holding that don’t care about the price of the stock like others do, although not nearly as many as there should be.
Pretty much.
They acquired a company with $5 million in profit and ties to Costco and..... this is all the volume we could muster? Disappointing, at least volume will come here one day.
You must have not been on this site long lol
Doesn’t look like the factory opening is far away at this point. Late fall is just around the corner. There isn’t really a comparable OTC out there that has the potential revenue and investors/validity like $RIII does. Big plans for this one.
No news on merger yet she's already running. Gonna be a really big merger this time.
Uh hello, can we get some support in here or what?
Sorry guys, but I think OPTI’s potential is severely limited now because of recent news about how UVC sanitizers have very little use against preventing coronavirus https://www.cnn.com/2020/08/20/health/coronavirus-ultraviolet-uvc-sanitizers-fda-wellness/index.html?utm_source=fbCNN&utm_medium=social&utm_content=2020-08-21T08%3A15%3A05&utm_term=link&fbclid=IwAR1y7Ozm1PDM9TNyHpe5SSFOec25kngLJK5Ztdp29pEw_F7MfpgYSyo0yjc.
On the Twitter account of Rob Van Dam, also known as Rob Szatkowski, you can see that he replied and said soon to a Twitter user asking when is his company reverse merging into UAPC. I’m not sure entirely sure what more proof you need
— Rob Van Dam (@TherealRVD) August 15, 2020,
Glad to see UAPC finally getting the recognition it deserves.
Had decided about them a while ago, good thing I didn’t buy into PAOG.
Do you think PAOG could end up being a scam like NOUV?
Read the stickiest post by i_like_bb_stock.
You asked what the ticker and company name where, even though both of those are listed multiple times on this page and in the url.
There will always be people that will be fine with 10% - 20% profit, even on possible explosive runners like this one.
If you’re selling shares now you probably shouldn’t be trading penny stocks.
Joey Gonzalez, the CEO of PASO, has an Instagram (joeygonz11) that you all should take a look at. Mentioned in a post a week ago that he has talked to two multi-billion-dollar firms, five world governments, ten fortune 100 firms, and two airlines in the past month. Hestia Partners is valued at being a twenty billion firm, CLX is following Chile, Brazil, India, and Saudi Arabia on Twitter, as well as being based in the US, and TransUnion is a Fortune 500 company. Oh yeah, it's all coming together
If the TransUnion presentation about what CLX will do to help keep the US economy open is in fact confirmed by CLX tomorrow as being true, and if the merger goes through tomorrow, then this stock could run very, very high.
Looks like someone didn't do an in-depth look at TLSS' 10-Q. In Q4 of 2019, they had a net loss of 6.9 million, in Q1 of 2020 that net loss was cut in HALF to 3.4 million. You can call coronavirus for the reason their net loss dropped, but most states didn't start shutting down until the middle of March, so the effect coronavirus had on increasing their revenue is nowhere near that of Q2, or later quarter earnings reports this year. Not impressed yet? In 2018 97% of their revenue came from working with Amazon, in 2019 it was 99%, in this quarter it was 75%. They decreased their dependence on Amazon a quarter AND cut their net loss in half. How difficult do you think that is to accomplish not one but both of those things. As you probably know, Amazon is a horrible business to work with, no matter if you're shipping for them or if you work in one of their warehouses, and in the long-term moving away from Amazon and instead working with primarily UPS or FedEx, if we are that lucky, will be great for their business. John Mercadante founded Leisure Lines Inc., which later ended up becoming one of the six separate business entities that formed together to create Coach USA, and he increased their revenue from 100 million to a billion in the span of just three years, so trust me when I say that TLSS can't be in better hands. If you want to whine on this board then fine, but when they hit a dollar, and they will by this time next year, I'm going to be sipping champagne on a beach in the Bahamas with all of the other investors that didn't chicken out when they dropped to five cents because Amazon dropped them back in June.
Oh my, that’s it. Our shares are never going under a penny again.
Instead of ClayTrader, y’all should be more worried about Timothy Sikes, because when he P&Ds a stock he does it with all of his effort
TSOI currently has 29 products it's working on. Using the average success rate from 2006-2015 of 9.6%, that means roughly 3 of those products would end up being approved by the FDA (https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf).
If each product earns one-hundred million each year, which considering most of the diseases TSOI is working to create cures for are widespread diseases the number could easily be doubled or tripled, that would TSOI three-hundred million in revenue, and if using a net income of .25 the number turns into 75 million. If you multiply seventy million with the average PE ratio for the pharmaceutical industry, which is 22.48, that would give out 1,686,000,000 (http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html). Divide that by the number of outstanding shares that TSOI currently has, 1,656,544,305 shares, and that leaves us with a potential PPS of 1.02. Potential life-changer here.
Well that was a cheap move. Haven’t touched any of my shares.